GBA Presents: RADIO SAVANT-!

Meta to cut 11,000 jobs as it looks to slash costs, affirms revenue outlook...

I don't usually look at other threads but there was a nice one about FB bottoming and I gave this info out then and gave my Bottom Call which appears to be EXACTLY ON TARGET!!!

GBA SCORES Again! MAKE IT EIGHT!!!!
 
A) BUY DISNEY.

I like Disney at $93 it's worked a few times for me- Re entering DIS today!

DIS The Walt Disney Company

$99.90-0.53(-0.53%)11:00 AM 11/08/22
NYSE |$USD |Pre-Market:$92.25-7.65(-7.66%)1:43 AM
 
Van when are you going to sell! THIS TSLA RECOMMENDATION IS THE WORST! Don't let Musk take you out he's such a creep.

Filings show Musk disposing of $4B in Tesla stock
 
B) Buy Terran Orbital

Terran Orbital GAAP EPS of -$0.19 beats by $0.04, revenue of $27.83M beats by $2.95M

Nov. 09, 2022 6:02 AM ETTerran Orbital Corporation (LLAP)
  • Terran Orbital(NYSE:LLAP): Q3 GAAP EPS of -$0.19beats by $0.04.
  • Revenue of $27.83M (+171.2% Y/Y)beats by $2.95M.
  • Backlog of $198.0 million as of September 30, 2022, up 168% since December 31, 2021
  • Increased headcount to greater than 440, up approximately 78% since the beginning of the year.
 
Innoviz Technologies GAAP EPS of -$0.69 misses by $0.45, revenue of $4.45M beats by $2.38M- Watch For Reaction
Nov. 09, 2022 6:02 AM ETInnoviz Technologies Ltd. (INVZ)
  • Innoviz Technologies(NASDAQ:INVZ): Q3 GAAP EPS of -$0.69misses by $0.45.
  • Revenue of $4.45M (+16.8% Y/Y)beats by $2.38M.
  • The company expects to increase its forward-looking order book by more than 30% by the end of 2022 and has already delivered a 165% increase year to date.
 
Excelerate Energy declares $0.025 dividend
Nov. 08, 2022 5:45 PM ET Excelerate Energy, Inc. (EE)B
  • Excelerate Energy (NYSE:EE) declares$0.025/share quarterly dividend, in line with previous.
  • Forward yield0.38%
  • Payable Dec. 14; for shareholders of record Nov. 22; ex-div Nov. 21.
  • Excelerate Energy's (EE) operating subsidiary Excelerate Energy Limited Partnership will make a corresponding distribution of $0.025 per interest to holders of its class B limited partnership interests on Dec. 14.

 
C) Buy IONIS- I've had this on the buy list for 3 days))))))))))))))))))))))))))

Ionis Pharmaceuticals backs 2022 revenue above $575M, consensus $594.45M 07:08 IONS
 
Back
Top